Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Marshall C. Freeman
Observed names:
Freeman, Marshall,
Marshall C Freeman,
Marshall Freeman
Institution:
Headache Wellness Center
Observed institutions:
Harvard University,
Headache & Pain Center of Palm Beach,
Headache Wellness Center,
Allergan (United States),
Columbia University
OpenAlex ID:
A5047020073
OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Analyses of the 56‐Week PREEMPT Clinical Program
2011
·
Sheena K. Aurora
, Paul Winner
, et al.
·
Headache The Journal of Head and Face Pain
·
297
Long-term study of the efficacy and safety of OnabotulinumtoxinA for the prevention of chronic migraine: COMPEL study
2018
·
Andrew M. Blumenfeld
, Richard J. Stark
, et al.
·
The Journal of Headache and Pain
·
197
PDF
Preventing Episodic Migraine With Caloric Vestibular Stimulation: A Randomized Controlled Trial
2017
·
David Wilkinson
, Kristen K. Ade
, et al.
·
Headache The Journal of Head and Face Pain
·
54
Efficacy of Duloxetine as a Migraine Preventive Medication: Possible Predictors of Response in a Retrospective Chart Review
2007
·
Anne P. Taylor
, James U. Adelman
, et al.
·
Headache The Journal of Head and Face Pain
·
35
The spectrum of response to erenumab in patients with chronic migraine and subgroup analysis of patients achieving ≥50%, ≥75%, and 100% response
2019
·
Jan Lewis Brandes
, Hans-Christoph Diener
, et al.
·
Cephalalgia
·
33
PDF
Cost Considerations of Acute Migraine Treatment
2004
·
James U. Adelman
, Leon C. Adelman
, et al.
·
Headache The Journal of Head and Face Pain
·
21
Electronic Medical Record System in a Headache Specialty Practice: A Patient Satisfaction Survey
2009
·
Marshall C. Freeman
, Anne P. Taylor
, et al.
·
Headache The Journal of Head and Face Pain
·
17
Pharmacoeconomics: The Cost of Prophylactic Migraine Treatments
2004
·
Leon C. Adelman
, James U. Adelman
, et al.
·
Headache The Journal of Head and Face Pain
·
4
Eptinezumab Achieved Meaningful Reductions in Migraine Activity Within 24 Hours That Were Sustained Through Week 12: Results From PROMISE-1 (PRevention Of Migraine via Intravenous eptinezumab Safety and Efficacy-1) Phase 3 Trial (P4.092)
2018
·
Timothy Smith
, David Biondi
, et al.
·
Neurology
·
2
Towards a standardized process of onboarding advanced practice providers into headache medicine practices in the United States: Expert consensus from the American Headache Society practice management committee
2026
·
Calli Cook
, Marshall C. Freeman
, et al.
·
Headache The Journal of Head and Face Pain
·
1
Towards a Standardized Process of Onboarding Advanced Practice Providers into Headache Medicine Practices in the United States (P1-12.009)
2025
·
Marshall Freeman
, Calli Cook
, et al.
·
Neurology
Tetany
2024
·
Marshall C. Freeman
·
Elsevier eBooks
Migraine-Preventive Medications: Guidelines for Success
2006
·
Marshall C. Freeman
Myokymia
2003
·
Marshall C. Freeman
·
Encyclopedia of the Neurological Sciences
Tetany
2003
·
Marshall C. Freeman
·
Encyclopedia of the Neurological Sciences
Show more works
View as search
Works count:
17
Citation count:
661
H-index:
7
I10-index:
7
Year
Topic
Type
